Nishadil
Signup Signin
Delhi | 25°C (windy)
AbbVie Unleashes Future Growth: $70 Million R&D and Manufacturing Hub Breaks Ground in Singapore

AbbVie Unleashes Future Growth: $70 Million R&D and Manufacturing Hub Breaks Ground in Singapore
Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs

Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs
Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule

Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule
The Drumbeat of Disinflation: Why the Federal Reserve is Poised to Cut Rates Once More

The Drumbeat of Disinflation: Why the Federal Reserve is Poised to Cut Rates Once More
Healthcare Shorts Take a Breather, But Moderna Remains Under the Microscope

Healthcare Shorts Take a Breather, But Moderna Remains Under the Microscope
Navigating the Path to Approval: Why REGENXBIO (RGNX) Remains a Strong Investment with RGX-121 for Hunter Syndrome

Navigating the Path to Approval: Why REGENXBIO (RGNX) Remains a Strong Investment with RGX-121 for Hunter Syndrome
Load more..